Efavirenz and Rifampicin (Rifcap 300 mg Kapsül): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Rifampin induction may lower efavirenz exposure.
Clinical significance and safety
Rifampin can reduce efavirenz exposure. Management depends on the exact product and patient circumstances; the HIV and tuberculosis teams should review treatment together without an unsupervised interruption.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.